Aurora Science

Aurora Science focuses on early-stage and startup equity investments, according to available research. The firm operates as a generalist venture investor, seeking direct positions in pre-scale companies. Specific stage boundaries — such as seed versus Series A typical check sizes — have not been publicly detailed.

Aurora Science is classified as an asset manager operating under a private equity strategy. Its limited public disclosure prevents confirmation of whether it functions as a single-family vehicle or an independent manager backed by third-party capital. The firm’s lean public profile often mirrors the operational style of a single-family office.

Aurora Science is headquartered in Milano, Italy, and deploys capital across Europe. Its investment mandate is not limited to a single sub-region, though specific country allocations or portfolio exposures outside Italy remain opaque.

The firm’s documented strategy covers early-stage and venture (general) investments, implying a direct deal orientation. No record of Aurora Science acting as a limited partner in external funds or running a fund-of-funds program has surfaced.

Sourcing mechanics are not publicly outlined. As a Milano-based firm with a concentrated investment mandate, deal flow likely originates from the principals' professional networks, local advisory relationships, and direct founder outreach rather than a broad institutional sourcing platform.